Posts Tagged ‘Rheumatoid arthritis news’
-
Pfizer’s JAK inhibitor Tofacitinib EMA Application Validated
Pfizer JAK-3 press release “Pfizer Announces European Medicines Agency Acceptance Of Regulatory Submission For Tofacitinib For The Treatment Of Rheumatoid Arthritis: Pfizer Inc. (NYSE:PFE) announced today that its Market Authorisation Application for tofacitinib (development code CP-690,550), a novel, oral JAK inhibitor being studied for the treatment of moderate-to-severe active rheumatoid arthritis (RA), has been validated [...]
-
Rheumatoid Arthritis Exercise, Round 5
This is the third post in the Frying Pan series to honor of the blog’s 3rd year, considering some significant issues from the last couple years. Sometimes the frying pan is more suitable than the sword. Today we’ll consider Rheumatoid Arthritis & exercise for the fifth time. The relationship between exercise and Rheumatoid Arthritis One [...]
-
A Paradigm Shift in Rheumatoid Arthritis Disease Activity? Part 2
In part 1 of A Paradigm Shift in Rheumatoid Arthritis Disease Activity, we considered some reasons why better ways of considering RA disease activity are needed. Ideally, three key things should be considered regarding RA disease activity: The patient’s estimation of his disease activity (more here). Appropriate monitoring using available tests (read more here!) A [...]
-
RA News Headlines, Vol. 6: Ibuprofen for Pain, Orencia Shots, New RA test, RA Inflammation Increases CV Risk
4 Big Headlines for RA News 1) Ibuprofen beats acetaminophen & a combination of both in knee pain Thanks to Dr. Kirsch for Tweeting this fantastic editorial about an arthritis pain relief study in the Annals of Rheumatic Diseases last week. The column highlights data in a new long-term study of the two most popular [...]
-
A Methotrexate Alternative for Rheumatoid Arthritis?
This molecule has “the potential to further improve the most successful principle of folate inhibition in the treatment” of Rheumatoid Arthritis. Folate antagonism has been the foundation of treatment for Rheumatoid Arthritis for almost two decades. Methotrexate is used to inhibit the proliferation of inflammatory cells, probably at least in part by folate antagonism. There [...]
-
Good News for Us and a Reader’s Take on the Newspaper
We’re so fortunate to have readers who make such amazing contributions. That’s what makes us more of a community than just a website. Isn’t it great the amount of information and encouragement readers provide each other – and me – even by commenting?! This week we reached an extraordinary milestone on our Facebook page. Our [...]
-
New Rheumatoid Arthritis Remission Criteria
One of the most fascinating things at ACR last November was the multi-presentation session on the last day focusing on creating Rheumatoid Arthritis remission criteria. We literally sat on the edge of our seats and took notes about the assorted characterizations of RA remission that have been used concurrently over the last couple of decades, [...]
-
Rheumatoid Arthritis News, Vol.5: Men & Mortality, Vitamin D Research, New RA Meds
Here are a couple of the Rheumatoid Arthritis news articles that have caught my eye recently or, in some cases, caused me to roll my eyes. More Rheumatoid Arthritis news worth mentioning 1) Big news w/Rheumatoid Arthritis in men:methotrexate fights mortality A study published last month found “men with rheumatoid arthritis were more than twice [...]
Subscribe to feed
